These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12879033)

  • 1. HIV drug resistance triggers strategic switch.
    Check E
    Nature; 2003 Jul; 424(6947):361. PubMed ID: 12879033
    [No Abstract]   [Full Text] [Related]  

  • 2. Accrued HIV evidence turns treatment dogma on its head.
    Check E
    Nature; 2003 Aug; 424(6951):866. PubMed ID: 12931150
    [No Abstract]   [Full Text] [Related]  

  • 3. Why HIV drug resistance matters: an overview.
    Learned J
    Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604
    [No Abstract]   [Full Text] [Related]  

  • 4. Using HIV resistance tests in clinical practice.
    Taylor S; Jayasuriya A; Smit E
    J Antimicrob Chemother; 2009 Aug; 64(2):218-22. PubMed ID: 19535382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into HIV resistance testing: nursing guidelines and implications.
    Kirton CA; Kurtyka D; Sterken DJ
    J Assoc Nurses AIDS Care; 2007; 18(3):74-86. PubMed ID: 17570302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia.
    Chkhartishvili N; Dvali N; Gochitashvili N; Sharvadze L; Tsertsvadze T
    Georgian Med News; 2008 Dec; (165):16-22. PubMed ID: 19124911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV resistance: frequency, testing, mechanisms.
    Kuritzkes DR
    Top HIV Med; 2007; 15(5):150-4. PubMed ID: 18073450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV drug resistance testing.
    AIDS Read; 2000 Mar; 10(3):149. PubMed ID: 10798889
    [No Abstract]   [Full Text] [Related]  

  • 9. Fact sheet on structured treatment interruption.
    Res Initiat Treat Action; 2003; 9(2):20-1. PubMed ID: 14989203
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic tests for HIV resistance are created as quickly as the new drugs. Research is leading individualized medicine evolution.
    AIDS Alert; 2006 Sep; 21(9):97-9. PubMed ID: 17019780
    [No Abstract]   [Full Text] [Related]  

  • 11. More HIV resistance testing needed, according to survey.
    AORN J; 2000 Aug; 72(2):307. PubMed ID: 11203501
    [No Abstract]   [Full Text] [Related]  

  • 12. The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing world.
    Bennett DE
    Curr Opin Infect Dis; 2006 Dec; 19(6):607-14. PubMed ID: 17075338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming resistance to existing therapies in HIV-infected patients: the role of new antiretroviral drugs.
    Perno CF; Moyle G; Tsoukas C; Ratanasuwan W; Gatell J; Schechter M
    J Med Virol; 2008 Apr; 80(4):565-76. PubMed ID: 18297706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits and limitations of testing for resistance to HIV drugs.
    Richman DD
    J Antimicrob Chemother; 2004 Apr; 53(4):555-7. PubMed ID: 15014064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and significance of minority quasispecies of drug-resistant HIV-1.
    Metzner KJ
    J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV drug resistance and you. Resistance overview. A look at the basics.
    Munk B
    Posit Aware; 2006; Spec No():6-9. PubMed ID: 16583502
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug resistance in antiretroviral therapy of HIV infection].
    Oette M; Häussinger D
    Med Klin (Munich); 2003 Dec; 98(12):692-9. PubMed ID: 14685670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Slow accumulation of HIV resistance mutations: implications for resource-limited settings?
    Stevens WS
    J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045
    [No Abstract]   [Full Text] [Related]  

  • 19. Companies aim at new HIV targets.
    Brower V
    Nat Biotechnol; 1996 Sep; 14(9):1079. PubMed ID: 9669875
    [No Abstract]   [Full Text] [Related]  

  • 20. The emergence of HIV resistance and new antiretrovirals: are we winning?
    Wainberg MA
    Drug Resist Updat; 2004 Jun; 7(3):163-7. PubMed ID: 15296858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.